Literature DB >> 19852667

Domain 3 of hepatitis C virus core protein is sufficient for intracellular lipid accumulation.

Ravi Jhaveri1, Guan Qiang, Anna Mae Diehl.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) is a major cause of liver disease worldwide, with steatosis, or "fatty liver," being a frequent histologic finding. In previous work, we identified sequence polymorphisms within domain 3 (d3) of genotype 3 HCV core protein that correlated with steatosis and in vitro lipid accumulation. In this study, we investigated the sufficiency of d3 to promote lipid accumulation, the role of HCV genotype in d3 lipid accumulation, and the subcellular distribution of d3.
METHODS: Stable cell lines expressing green fluorescent protein (GFP) fusions with isolates of HCV genotype 3 core steatosis-associated d3 (d3S), non-steatosis-associated d3 (d3NS), and genotype 1 d3 (d3G1) were analyzed by means of immunofluorescence, oil red O (ORO) staining, and triglyceride quantitation.
RESULTS: Cells that expressed d3S had statistically significantly more ORO than did cells expressing d3NS or d3G1 (P=.02 and <.001, respectively), as well as higher triglyceride levels P =.03 and .003, respectively). Immunofluorescence analysis showed that d3 does not colocalize to lipid droplets but partially colocalizes to the Golgi apparatus.
CONCLUSIONS: Our results suggest that HCV core d3 is sufficient to mediate the accumulation of lipid by means of a mechanism that is independent of domains 1 and 2. Our results also suggest that altered lipid trafficking may be involved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19852667      PMCID: PMC2783228          DOI: 10.1086/648094

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

Review 1.  Hepatitis C virus core protein: possible roles in viral pathogenesis.

Authors:  M M Lai; C F Ware
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes.

Authors:  M K Lemberg; F A Bland; A Weihofen; V M Braud; B Martoglio
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 3.  Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always.

Authors:  Francesco Negro
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 4.  The molecular biology of hepatitis C virus. Genotypes and quasispecies.

Authors:  X Forns; J Bukh
Journal:  Clin Liver Dis       Date:  1999-11       Impact factor: 6.126

5.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors:  L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

6.  Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.

Authors:  Gabriel Perlemuter; Abdelmajid Sabile; Philippe Letteron; Giovanna Vona; André Topilco; Yves Chrétien; Kazuhiko Koike; Dominique Pessayre; John Chapman; Giovanna Barba; Christian Bréchot
Journal:  FASEB J       Date:  2002-02       Impact factor: 5.191

7.  Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

Authors:  L E Adinolfi; R Utili; A Andreana; M F Tripodi; M Marracino; M Gambardella; M Giordano; G Ruggiero
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

8.  Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment.

Authors:  V Pène; C Hernandez; C Vauloup-Fellous; J Garaud-Aunis; A R Rosenberg
Journal:  J Viral Hepat       Date:  2009-03-05       Impact factor: 3.728

9.  Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets.

Authors:  John McLauchlan; Marius K Lemberg; Graham Hope; Bruno Martoglio
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

10.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.

Authors:  Johan Westin; Hans Nordlinder; Martin Lagging; Gunnar Norkrans; Rune Wejstål
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

View more
  6 in total

1.  Role of Capsid Anchor in the Morphogenesis of Zika Virus.

Authors:  Jyoti Rana; José Luis Slon Campos; Gabriella Leccese; Maura Francolini; Marco Bestagno; Monica Poggianella; Oscar R Burrone
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.

Authors:  Mary A Rodgers; Valerie A Villareal; Esperance A Schaefer; Lee F Peng; Kathleen E Corey; Raymond T Chung; Priscilla L Yang
Journal:  J Am Chem Soc       Date:  2012-04-11       Impact factor: 15.419

3.  Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis.

Authors:  Marion Depla; Louis d'Alteroche; Amélie Le Gouge; Alain Moreau; Christophe Hourioux; Jean-Christophe Meunier; Julien Gaillard; Anne de Muret; Yannick Bacq; Farhad Kazemi; Aurélie Avargues; Emmanuelle Roch; Eric Piver; Catherine Gaudy-Graffin; Bruno Giraudeau; Philippe Roingeard
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

4.  Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1-3 Strains and Does Not Correlate with Virus Replication.

Authors:  Andrea Galli; Santseharay Ramirez; Jens Bukh
Journal:  Viruses       Date:  2021-02-28       Impact factor: 5.048

5.  Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.

Authors:  Rossana C Jaspe; Yoneira F Sulbarán; Maria Z Sulbarán; Carmen L Loureiro; Hector R Rangel; Flor H Pujol
Journal:  Virol J       Date:  2012-09-21       Impact factor: 4.099

6.  Lipid droplet binding of hepatitis C virus core protein genotype 3.

Authors:  Guan Qiang; Ravi Jhaveri
Journal:  ISRN Gastroenterol       Date:  2012-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.